Pacira BioSciences stockPCRX
Pacira BioSciences trades at $36.42, 0.7% below its 52-week high (Oct 15, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +40.7% year to date, +66.7% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for PCRX — after you log in
Open the terminalFrequently asked questions about Pacira BioSciences
What is the Pacira BioSciences stock price?
At the close on Nov 5, 2026: $36.42 (+0.05% on the day). 52-week high: $36.66 on Oct 15, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Pacira BioSciences report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed −1% year over year, revenue +6%.
Does Pacira BioSciences pay dividends?
No, Pacira BioSciences does not pay dividends.
Where does Pacira BioSciences trade and how to buy it?
Ticker PCRX, exchange Nasdaq, listed since 2011. You can buy it through a broker with access to US exchanges.
Should I buy Pacira BioSciences now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for PCRX are in the terminal after you log in.